Glycomics Market: Introduction

According to the report, the global glycomics market was valued at US$ 0.9 Bn in 2020 and is projected to expand at a CAGR of 11.2% from 2021 to 2031. Increase in R&D activities to develop novel and efficient therapies to meet unmet medical needs across the globe drives the demand for new glycomics and glycobiology tools. This is projected to boost the growth of the global glycomics market during the forecast period. North America dominated the global glycomics market in 2020, and the trend is anticipated to continue during the forecast period. This can be attributed to increase in R&D investments in pharmaceutical companies & research institutes for new drug development and presence of major research laboratories, and pharmaceutical & biotechnology companies in the region.

The glycomics market in Asia Pacific is expected to expand at a CAGR of 12.2% from 2021 to 2031. Rise in development of new vaccines for genetic diseases such as diabetes and influenza is likely to drive the market in the region during the forecast period. This, in turn, is projected to drive the demand for glycomics in emerging markets such as India and China.

Request Brochure of Report -

Advent of New Technology to Drive Global Market

The glycomics market has witnessed significant investments by multinational corporates in the past few years. These business conglomerates have invested in companies operating in the glycomics market. Agilent Technologies, Inc. completed the acquisition of Resolution Bioscience. The acquisition expanded the company in the fast-growing NGS market for precision oncology. Resolution Bioscience complements and expands Agilent’s capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to serve the needs of the fast-growing precision medicine market.

Bruker Corporation announced the acquisition of InVivo Biotech Services GmbH, a leading provider of monoclonal antibodies and recombinant proteins. The acquisition is expected to strengthen the company’s expertise and leadership in preclinical imaging. Through this, Bruker Corporation aims to expand its microbiology assay menu.

New England Biolabs announced the release of its newest loop-mediated isothermal amplification (LAMP) products, the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix (with UDG) and the WarmStart Fluorescent LAMP/RT-LAMP Kit (with UDG), which combines the master mix and LAMP fluorescent dye in one convenient kit.

Thermo Fisher Scientific, Inc. introduced a new generation, high resolution mass spectrometer (MS), designed to give proteomics, metabolomics, biopharmaceutical characterization, and small-molecule scientists the analytical performance required for research and high-throughput analyses. The new system will help drive discovery and identification with increased accuracy for confident scale-up, while operational simplicity and speed streamline time to results.

Request for Analysis of COVID-19 Impact on Glycomics Market -

Enzymes Dominated Glycomics Market

In terms of product type, the global glycomics market has been classified into enzymes, instruments, kits, and reagents. The enzymes segment dominated the global glycomics market in 2020, and the trend is anticipated to continue during the forecast period. The increase in demand for enzymes is expected to drive the segment over the next few years.

Drug Discovery & Development to Lead Glycomics Market

Based on application, the global glycomics market has been categorized into diagnostics, drug discovery & development, oncology immunology, and others. The drug discovery & development segment dominated the global glycomics market in 2020 and the trend is likely to continue during the forecast period.

Pharmaceutical & Biotechnology Companies to be Promising End-users

In terms of end-user, the global glycomics market has been divided into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations. The pharmaceutical & biotechnology companies segment held major share of the global glycomics market in 2020.

Buy Glycomics Market Report at

Asia Pacific to Dominate Global Market

The global glycomics market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Asia Pacific is projected to account for a leading share of the global glycomics market during the forecast period, owing to increase in the number of patients suffering from chronic diseases in hospitals. The glycomics market in Asia Pacific is anticipated to grow at a rapid pace over the next few years. India, China, and South Korea are expected to be lucrative markets in the near future.

Glycomics Market: Key Players

Key players operating in the global glycomics market are Agilent Technologies, Inc., Asparia Glycomics, Bruker Corporation, Canadian Glycomics Network (GLYCONET), Glyco Expression Technologies, Inc., Glycodiag, Merck KGaA, New England Biolabs, RayBiotech, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Vector Laboratories, and Glyde Bio, Inc.

More Trending Reports by Transparency Market Research –

Scar Treatment Market

Adhesion Barriers Market:

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Contact Us

Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453